Sage Therapeutics, Inc. Annual Return On Assets in % from 2015 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sage Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2024.
  • Sage Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2024 was -60.8 %, a 16.1% decline year-over-year.
  • Sage Therapeutics, Inc. annual Return On Assets for 2024 was -60.8 %, a 16.1% decline from 2023.
  • Sage Therapeutics, Inc. annual Return On Assets for 2023 was -52.4 %, a 51.2% decline from 2022.
  • Sage Therapeutics, Inc. annual Return On Assets for 2022 was -34.7 %, a 48.5% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -60.8 -8.45 -16.1% Jan 1, 2024 Dec 31, 2024
2023 -52.4 -17.7 -51.2% Jan 1, 2023 Dec 31, 2023
2022 -34.7 -11.3 -48.5% Jan 1, 2022 Dec 31, 2022
2021 -23.3 -75.3 -145% Jan 1, 2021 Dec 31, 2021
2020 51.9 +106 Jan 1, 2020 Dec 31, 2020
2019 -54.1 -18.9 -53.5% Jan 1, 2019 Dec 31, 2019
2018 -35.3 +40.5 +53.5% Jan 1, 2018 Dec 31, 2018
2017 -75.8 -31 -69.2% Jan 1, 2017 Dec 31, 2017
2016 -44.8 +6.2 +12.2% Jan 1, 2016 Dec 31, 2016
2015 -51 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.